Yoann Pradat
Villejuif, 94805, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
fRagmentomics: an R package for integrating cell-free DNA fragment features with mutational status to support liquid biopsy interpretation.
Journal: Bioinformatics (Oxford, England)
Published: November 04, 2025
Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 study.
Journal: Cancer cell
Published: July 07, 2025
Patritumab deruxtecan in HR+HER2- advanced breast cancer: a phase 2 trial.
Journal: Nature medicine
Published: March 31, 2025
Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER-positive/HER2-negative breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 20, 2024
Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer.
Journal: Cancer discovery
Published: December 23, 2022
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial.
Journal: Nature medicine
Published: September 20, 2022
CustOmics: A versatile deep-learning based strategy for multi-omics integration.
Journal: PLoS computational biology
Published: September 14, 2022
Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer.
Journal: Cancer discovery
Published: August 31, 2022
Unified classification and risk-stratification in Acute Myeloid Leukemia.
Journal: Nature communications
Published: February 10, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026